Latest News in Pharma industry3 days agoRevolutionizing Drug Testing: Intelligent Bio Solutions Unveils Groundbreaking Fingerprint Sweat Analysis3 days agoEMA Reverses Stance: Limited Approval of Alzheimer's Drug Leqembi Brings Hope and Caution to Europe4 days agoSyros Pharmaceuticals Crashes: Major Trial Failure Sparks 76% Stock Plunge and Loan Default5 days agoBioNTech's $1 Billion Gamble: Bold Acquisition of Chinese Biotech Firm to Revolutionize Cancer Treatment5 days agoDongyangguang Pharma Strikes Landmark Global Deal with Apollo to Revolutionize Diabetes and Obesity Treatment5 days agoJohnson & Johnson to Cut Thousands of Jobs in China Amid Major Market Overhaul6 days agoNuzyra Shows Promising Results in Tough-to-Treat NTM Lung Disease6 days agoAbbVie’s $40 Billion Setback: Emraclidine Trial Failure Shakes Pharma Market and Exposes Neuroscience Challenges9 days agoTezspire Shakes Up Biopharma Market with Breakthrough CRSwNP Trial Results, Poised to Challenge Dupixent's Reign9 days agoTezspire Shakes Up Biopharma Market with Breakthrough CRSwNP Trial Results, Poised to Challenge Dupixent's Reign10 days agoGroundbreaking Mpox Vaccine Trial Targets Pregnant Women and Infants: A Game-Changer for Global Health?11 days agoTrump's Healthcare Overhaul: What Changes, Challenges, and Opportunities Lie Ahead?13 days agoTEV-479: A Game-Changer in Schizophrenia Treatment with Breakthrough Phase III Results16 days agoApotex Eyes Landmark 2024 IPO: Paving the Way for Affordable Healthcare and Industry Innovation16 days agoSunbird Bio's 86% Accurate Blood Test for Parkinson's: A Major Leap in Non-Invasive Diagnostics18 days agoAstraZeneca China President Lei Wang Under Investigation Amid Major Healthcare Fraud Allegations18 days agoBreakthrough Phase II Trial Launches Hope for Glioblastoma Patients: Ropidoxuridine Aims to Redefine Survival19 days agoTremfya and Omvoh Set to Revolutionize Crohn’s Disease Treatment with Impressive Trial Results19 days agoModerna and MSD Launch Groundbreaking Trial for Personalized Lung Cancer Treatment with mRNA Therapy20 days agoPfizer Boosts 2024 Forecast Amid Rising Pressure from Activist Investor Over $20B 'Lost Value'23 days agoAbbott's TEAM-HF Trial Explores Early HeartMate 3 Use to Revolutionize Heart Failure Treatment25 days agoGenelux Kicks Off Phase II VIRO-25 Trial: A New Hope for Recurrent NSCLC with Innovative Olvi-Vec Therapy26 days agoEli Lilly's Alzheimer's Drug Faces NICE Rejection Over Cost Concerns, Final Decision Looms26 days agoFDA Puts BioNTech's Gotistobart Phase III Trial on Hold Over Varying NSCLC Results: What's Next?27 days agoEndospan Completes Key Enrollment Milestone in Groundbreaking Aortic Arch Disease Clinical Trial28 days agoCD&R to Acquire Sanofi’s €15 Billion Opella: A Tech-Driven Healthcare Leader in the Making30 days agoMerck's Game-Changing RSV Vaccine, Clesrovimab, Set for 2025 Launch After Breakthrough Trial Results31 days agoGlaukos Eyes FDA Approval for Breakthrough Keratoconus Therapy After Positive Phase III Results32 days agoJohnson & Johnson Advances Surgical Robotics with Ottava: FDA Submission Sets Stage for Market Disruption34 days agoEli Lilly's Omvoh Outshines Stelara in Landmark Crohn's Disease Trial35 days agoCapricor Therapeutics Reports Promising 3-Year Results for Duchenne Muscular Dystrophy Therapy Deramiocel37 days agoPfizer’s Hympavzi Wins FDA Approval: A Groundbreaking Once-Weekly Treatment for Hemophilia38 days agoRivanna's AI-Powered Accuro XV Set to Revolutionize Emergency Care with Groundbreaking Imaging Technology39 days agoAllurion’s Intragastric Balloon Shows Promising Results, But Faces Tough Competition from Breakthrough GLP-1 Weight Loss Drugs39 days agoGSK Settles $2.2 Billion Zantac Lawsuits, Resolves 93% of Claims and Sees Stock Surge39 days agoBayer Stock Plunges as U.S. Court Reopens Monsanto Case Amid $1.5B PCB Litigation Crisis40 days agoLenacapavir: Gilead’s $5 Billion Breakthrough Set to Dominate HIV Prevention and Revolutionize Public Health41 days agoRevolutionary Fish-Skin Grafts Heal Diabetic Foot Ulcers Faster: A Game-Changer in Wound Care44 days agoAvistone Expands Groundbreaking Phase I Trial for ANS014004: A Next-Generation MET Inhibitor Targeting Resistant Cancers46 days agoProcessa Pharmaceuticals Launches Phase II Trial for Enhanced Breast Cancer Treatment46 days agoBioNTech Unveils Groundbreaking AI for Personalized Medicine, But Experts Warn of 'Proof-of-Concept' Limitations46 days agoSynchron’s Groundbreaking Stentrode BCI Shows Promising Results in 12-Month Paralysis Trial, Paving the Way for Thought-Controlled Devices47 days agoGenentech Acquires Regor’s CDK Inhibitors in $850M Deal to Revolutionize Breast Cancer Treatment48 days agoJohnson & Johnson's Yuvanci Wins European Approval: First Single-Tablet Therapy for Pulmonary Arterial Hypertension48 days agoCVS Health Explores Major Breakup Amid Struggles in Medicare and Declining Stock51 days agoFDA Greenlights Dupixent as First Biologic for COPD: A Breakthrough in Respiratory Treatment and Market Expansion51 days agoBreakthrough in Parkinson's Treatment: AbbVie's Tavapadon Shines in Phase III Trial, Offering New Hope for Millions52 days agoBreakthrough Antibody SC27 Neutralizes All COVID-19 Variants: A Promising Step Toward Ending the Pandemic52 days agoPfizer's $5.4 Billion Gamble Crumbles: Oxbryta Withdrawal Sparks Biotech Gold Rush in Sickle Cell Arena52 days agoRevolutionary Brain Shunt Unlocks Gateway for Gene Therapy: CereVasc's eShunt System Breaks Barriers in CNS Drug DeliveryLoad More
